Microchip Technology Inc. filings document operating results, material events, governance matters, and capital-structure disclosures for a public semiconductor company. Form 8-K reports include quarterly and annual results, financial-condition exhibits, material-event disclosures, material agreements, and securities information for common stock and depositary shares representing interests in 7.50% Series A Mandatory Convertible Preferred Stock.
Proxy and annual meeting filings cover board elections, auditor ratification, executive compensation, shareholder voting matters, and related governance disclosures. The company’s regulatory record also provides formal disclosure on security listings, stockholder approvals, and the corporate actions and risk topics associated with its semiconductor product portfolio and public-company obligations.
MICROCHIP TECHNOLOGY INC (MCHP) reported insider equity activity by Mathew B. Bunker, its Senior Corporate Vice President, Operations. On August 15, 2026, he exercised and converted performance stock units and restricted stock units into 4,118 shares of common stock at an exercise price of $80.26 per share, with 1,150 shares delivered or withheld to cover the exercise price or tax liabilities. The performance stock units were earned based on Microchip’s cumulative non-GAAP operating margin over 12 quarters ending June 30, 2025, targeting a 40.0% margin, and vested on August 15, 2026, with vested shares delivered upon vesting.
MICROCHIP TECHNOLOGY INC (MCHP) reported that Chief Operating Officer Richard J. Simoncic had equity awards vest and convert into common stock on August 17, 2026. 2,226 Restricted Stock Units vested and were delivered in common shares, and 1,952 Performance Stock Units earned under a 12‑quarter performance period ending June 30, 2025 also vested and converted into common stock. The resulting 4,178 common shares were held indirectly in a trust, at a stated value of $80.26 per share. In separate code F transactions, 943 shares and 827 shares of common stock held by the trust were delivered or withheld to satisfy the exercise price or tax liability associated with these vestings.
MICROCHIP TECHNOLOGY INC (MCHP) reported that President and CEO Steve Sanghi exercised and vested equity awards tied to company performance. On August 17, 2026, restricted stock units for 7,020 shares and performance stock units for 6,157 shares converted into common stock at an exercise price of $80.26 per share. A total of 2,903 and 2,546 common shares were delivered or withheld to cover the exercise price or tax liabilities. Footnotes state that roughly 9.4 million shares are held indirectly through The Sanghi Trust and The Sanghi Family Limited Partnership.
Microchip Technology Inc. (MCHP) reported that Senior Corporate VP and CFO James Eric Bjornholt had Restricted Stock Units and Performance Stock Units convert into a total of 4,178 shares of common stock on August 17, 2026, held indirectly through a trust. Of these, 954 shares were delivered or withheld to cover exercise price or tax liability, and 837 shares were sold at $80.26 per share.
The RSUs vest in full on August 17, 2026, contingent on continued service. The PSUs were earned based on Microchip’s cumulative non-GAAP operating margin over 12 quarters ending June 30, 2025, with target awards tied to a 40.0% margin.
For MICROCHIP TECHNOLOGY INC (MCHP), director Karen Marie Rapp reported equity compensation activity. On August 18, 2026, she received a grant of 2,557 Restricted Stock Units, each representing a contingent right to one share of common stock, scheduled to vest in full on August 18, 2027 as long as she remains a service provider through that date; vested shares will then be delivered to her. On August 17, 2026, 3,090 Restricted Stock Units vested in full and were converted into 3,090 shares of common stock at a stated value of $80.26 per share, increasing her directly held common stock position to 14,227 shares after the transactions.
MICROCHIP TECHNOLOGY INC (MCHP) director Victor Peng reported equity compensation activity involving restricted stock units and common stock. On August 18, 2026, he received a grant of 2,557 Restricted Stock Units, each representing a contingent right to one share of common stock; these RSUs will vest in full on August 18, 2027 if he remains a service provider, with shares delivered upon vesting.
On August 17, 2026, 3,090 Restricted Stock Units vested in full and were converted into 3,090 shares of common stock at an exercise price of $80.26 per share, with vested shares delivered to him upon vest. Following this conversion, he held 5,416 shares of common stock indirectly, including 5,370 shares held by The Peng Revocable Trust and 46 shares held in an IRA in his name.
MICROCHIP TECHNOLOGY INC (MCHP) reported equity compensation and a routine equity settlement for director Mitchell R. Little. On August 18, 2026, he received a grant of 2,557 Restricted Stock Units, each representing one share of common stock, scheduled to vest in full on August 18, 2027 if he remains a service provider. On August 17, 2026, 472 RSUs vested in full and were converted into 472 shares of common stock at $80.26 per share, increasing his directly held common stock to 1,558 shares.
MICROCHIP TECHNOLOGY INC (MCHP) reported equity compensation activity for director Richard B. Cassidy II. On August 18, 2026 he received a grant of 2,557 Restricted Stock Units (RSUs), each representing a contingent right to one share of common stock; these RSUs will vest in full on August 18, 2027 as long as he remains a service provider, with shares delivered upon vesting. On August 17, 2026 a prior RSU award of 3,090 units vested in full, and the units were converted into 3,090 shares of common stock at a stated value of $80.26 per share, increasing his directly held common stock to 4,348 shares.
MICROCHIP TECHNOLOGY INC (MCHP) director Matthew W. Chapman reported equity compensation and a related share delivery. On August 18, 2026, he received a grant of 2,557 Restricted Stock Units, each representing a contingent right to one share of common stock, which will vest in full on August 18, 2027 as long as he remains a service provider through that date; vested shares will then be delivered to him.
On August 17, 2026, 3,090 Restricted Stock Units vested in full and the corresponding 3,090 shares of common stock were delivered to him at an exercise/conversion price of $80.26 per share. Following this delivery, he directly held 20,755 shares of common stock.
MICROCHIP TECHNOLOGY INC (MCHP) reported insider equity activity by director Ellen Barker. On August 18, 2026, she received a grant of 2,557 Restricted Stock Units (RSUs), each representing one share of common stock, scheduled to vest in full on August 18, 2027, contingent on continued service. On August 17, 2026, 3,090 RSUs vested in full and were converted into 3,090 shares of common stock at an exercise price of $80.26 per share, increasing her directly held common stock position to 6,887 shares.